LC-MS/MS: HT analysis of Ivacaftor, and Lumacaftor in CF| Protocol preview

LC-MS/MS: HT analysis of Ivacaftor, and Lumacaftor in CF| Protocol preview

LC-MS/MS Enables Rapid Quantitative Analysis of Over 200 Veterinary DrugsПодробнее

LC-MS/MS Enables Rapid Quantitative Analysis of Over 200 Veterinary Drugs

LCM-LC/MS to quantify Drugs in Pulmonary Tuberculosis Lesions| Protocol PreviewПодробнее

LCM-LC/MS to quantify Drugs in Pulmonary Tuberculosis Lesions| Protocol Preview

Data from Qualification of LC-MS HCP analysisПодробнее

Data from Qualification of LC-MS HCP analysis

John Lesser - Update on the MHI Experience With FFR-CT - 1/16/2017Подробнее

John Lesser - Update on the MHI Experience With FFR-CT - 1/16/2017

Matthew Nesbitt, MSc- Enrichment of cffDNA and ctDNA via size selection for reduced diagnostic..Подробнее

Matthew Nesbitt, MSc- Enrichment of cffDNA and ctDNA via size selection for reduced diagnostic..

Oligonucleotide Analysis by LC and LC-MSПодробнее

Oligonucleotide Analysis by LC and LC-MS

Quantification of Biologics by LC MSПодробнее

Quantification of Biologics by LC MS

LC-MS/MS Diagnostic Fragmentation Filtering: Application-Microcystin Analysis l Protocol PreviewПодробнее

LC-MS/MS Diagnostic Fragmentation Filtering: Application-Microcystin Analysis l Protocol Preview

The Role of LC MS in Glycoscience ResearchПодробнее

The Role of LC MS in Glycoscience Research

Fisher, Luke: ALE of Halobacterium salinarum NRC-1 & Escherichia coli MG1655 under MgCl2 stressПодробнее

Fisher, Luke: ALE of Halobacterium salinarum NRC-1 & Escherichia coli MG1655 under MgCl2 stress

Dr Christian Frezza's lab overviewПодробнее

Dr Christian Frezza's lab overview

CE-ICP-MS For Quantification-Iron Redox Species (Fe(II), Fe(III)) l Protocol PreviewПодробнее

CE-ICP-MS For Quantification-Iron Redox Species (Fe(II), Fe(III)) l Protocol Preview

NGBS2020: Theory and Simulation - G.Andrés CisernosПодробнее

NGBS2020: Theory and Simulation - G.Andrés Cisernos

Why is LC-MS analysis of HCPs challenging?Подробнее

Why is LC-MS analysis of HCPs challenging?

How fractionation at analytical LC scale accelerates mRNA therapeutics development at CureVacAGПодробнее

How fractionation at analytical LC scale accelerates mRNA therapeutics development at CureVacAG

Dr. Chaft on Ongoing Pivotal Trials in EGFR-Mutant NSCLCПодробнее

Dr. Chaft on Ongoing Pivotal Trials in EGFR-Mutant NSCLC

Qualification of LC-MS HCP analysisПодробнее

Qualification of LC-MS HCP analysis

Advances in Fluorescence Guided Resection of Glioma Fluorescein vs ALA - Shawn Hervey Jumper, MDПодробнее

Advances in Fluorescence Guided Resection of Glioma Fluorescein vs ALA - Shawn Hervey Jumper, MD

miRNAs in CSF as Prodromal Biomarkers for Huntington's DiseaseПодробнее

miRNAs in CSF as Prodromal Biomarkers for Huntington's Disease